Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Diclofenac Sodium prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 46.5/KG in Q1 to USD 49.3/KG by Q2 as spring musculoskeletal pain and post-operative analgesic formulation procurement and firmer phenylacetic acid synthesis feedstock costs drove consistent buying following the brief Q1 2026 pricing correction. Globally, the average rose from USD 32.62/KG in Q1 to USD 34.58/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 34.90-38.80/KG is expected, with continued firming on Middle East supply disruptions and growing NSAID and analgesic sector demand globally.
Diclofenac Sodium is a phenylacetic acid-derived NSAID produced by multi-step synthesis from 2,6-dichloroaniline and phenylacetic acid through N-acylation, intramolecular cyclisation, and sodium salt formation to yield sodium 2-[(2,6-dichlorophenyl)amino]phenylacetate. The compound exerts its anti-inflammatory, analgesic, and antipyretic effects through preferential cyclooxygenase-2 over cyclooxygenase-1 inhibition, reducing prostaglandin biosynthesis in inflamed tissues with greater gastrointestinal mucosal protection than non-selective NSAIDs. The largest pull comes from oral and parenteral musculoskeletal pain management covering osteoarthritis joint pain, rheumatoid arthritis, ankylosing spondylitis, and acute low back pain across outpatient and hospital settings globally. Post-operative and post-traumatic analgesia in institutional formulations adds significant demand. Topical gel and patch formulations for localised osteoarthritis joint and soft tissue sports injury pain management add a substantial and growing consumer and clinical segment. Ophthalmic NSAID drops for post-cataract surgery and corneal refractive procedure inflammation and pain add further consistent demand. Dysmenorrhoea management adds an additional volume segment globally. Phenylacetic acid synthesis feedstock costs, NSAID prescription volumes, and regional API production capacity all feed into the price.
The balance of supply and demand for Diclofenac Sodium through H2 2026 leans moderately firm. Phenylacetic acid and aniline synthesis feedstock costs firmed from Middle East supply disruptions. Musculoskeletal pain management, post-operative analgesia, and topical anti-inflammatory formulation demand are growing with an ageing global population and expanding arthritis disease burden.
The main upside risk is synthesis feedstock cost increases alongside accelerating musculoskeletal disease management and sports medicine topical formulation demand. The main downside risk is continued Chinese API surplus and generic competition limiting the global price recovery below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 34.90 - 38.80 | Synthesis cost firming and NSAID/analgesic demand support |
| United States | 37.30 - 41.20 | Steady musculoskeletal and post-operative demand holds firm |
| China | 25.00 - 28.90 | Large API capacity keeps it the most affordable |
| Germany | 49.70 - 53.60 | High synthesis and energy costs keep it the most expensive |
| India | 35.90 - 39.80 | Growing NSAID and export demand holds a firm middle |
US Diclofenac Sodium prices averaged USD 40.0/KG in Q2 2026, up 6.1% from USD 37.7/KG in Q1 2026. Firmer synthesis feedstock costs and spring musculoskeletal pain and post-operative analgesic procurement drove consistent buying following the Q1 correction.
Why did the price of Diclofenac Sodium change in Q2 2026 in the United States?
Firmer phenylacetic acid synthesis feedstock costs raised the API production floor. Musculoskeletal pain, post-operative analgesic, and topical gel procurement lifted buying. Ophthalmic NSAID eye drop and sports injury topical demand provided additional support near USD 40.0/KG.
Chinese Diclofenac Sodium prices averaged USD 27.9/KG in Q2 2026, up 6.1% from USD 26.3/KG in Q1 2026, the lowest among the tracked markets. Spring NSAID and analgesic export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the production floor despite domestic API capacity.
Why did the price of Diclofenac Sodium change in Q2 2026 in China?
Spring musculoskeletal and analgesic export and domestic procurement lifted buying. Firmer domestic phenylacetic acid synthesis costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Diclofenac Sodium prices averaged USD 49.3/KG in Q2 2026, up 6.0% from USD 46.5/KG in Q1 2026, the highest among the tracked markets. Higher synthesis feedstock and energy costs elevated European API production economics. Consistent musculoskeletal pain, post-operative analgesic, and topical anti-inflammatory demand maintained consistent buying.
Why did the price of Diclofenac Sodium change in Q2 2026 in Germany?
Higher phenylacetic acid synthesis feedstock and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to aromatic synthesis feedstock chains. Consistent musculoskeletal pain and post-operative analgesic procurement maintained buying near USD 49.3/KG.
Indian Diclofenac Sodium prices averaged USD 37.6/KG in Q2 2026, up 5.9% from USD 35.5/KG in Q1 2026. Growing NSAID export and domestic musculoskeletal pain demand supported buying. Firmer synthesis feedstock import costs raised the production floor.
Why did the price of Diclofenac Sodium change in Q2 2026 in India?
Growing musculoskeletal pain and analgesic export and domestic procurement lifted buying. Firmer phenylacetic acid synthesis import costs raised the production floor. Topical gel and ophthalmic NSAID export demand provided additional support near USD 37.6/KG.
US Diclofenac Sodium prices averaged USD 37.7/KG in Q1 2026, easing about 2.1% from Q4 2025. Post-year-end musculoskeletal pain and analgesic procurement moderation and soft synthesis costs eased the market before the Q2 spring season recovery.
Why did the price of Diclofenac Sodium change in Q1 2026 in the United States?
Post-year-end musculoskeletal and analgesic procurement moderation reduced buying urgency. Soft synthesis feedstock costs eased the API production floor. The market eased to USD 37.7/KG before the Q2 spring musculoskeletal procurement recovery.
Chinese prices averaged USD 26.3/KG in Q1 2026, easing about 1.9% from Q4 2025. Post-Lunar New Year procurement moderation and soft synthesis costs held the market near USD 26.3/KG.
Why did the price of Diclofenac Sodium change in Q1 2026 in China?
Post-Lunar New Year NSAID export and domestic procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 26.3/KG before the Q2 recovery.
German prices averaged USD 46.5/KG in Q1 2026, easing about 1.9% from Q4 2025. Post-year-end musculoskeletal and analgesic procurement moderation and soft synthesis costs eased the market near USD 46.5/KG.
Why did the price of Diclofenac Sodium change in Q1 2026 in Germany?
Post-year-end musculoskeletal pain and analgesic procurement moderation reduced urgency. Soft synthesis feedstock and energy costs eased the production floor. The market eased to USD 46.5/KG before the Q2 spring procurement recovery.
Indian prices averaged USD 35.5/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-holiday procurement moderation and soft synthesis import costs held the market near USD 35.5/KG.
Why did the price of Diclofenac Sodium change in Q1 2026 in India?
Post-holiday NSAID and analgesic procurement moderation reduced urgency. Soft synthesis import costs eased the production floor. The market eased to USD 35.5/KG before the Q2 spring recovery.
Global Diclofenac Sodium prices firmed through Q3 and Q4 2025 on the musculoskeletal pain management season, corrected in Q1 2026 on post-year-end procurement moderation, then surged in Q2 2026. The average rose from USD 32.0/KG in Q2 2025 to USD 32.64/KG in Q3 and USD 33.29/KG in Q4, eased to USD 32.62/KG in Q1 2026, then surged to USD 34.58/KG in Q2 2026, a net gain of about 8.1% over the window. Phenylacetic acid synthesis feedstock cycles and NSAID analgesic procurement seasonality drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 34.58 | +6.0% | ↑ Rising |
| Q1 2026 | 32.62 | -2.0% | ↓ Falling |
| Q4 2025 | 33.29 | +2.0% | ↑ Rising |
| Q3 2025 | 32.64 | +2.0% | ↑ Rising |
| Q2 2025 | 32.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Diclofenac Sodium prices firmed steadily through 2025 on consistent musculoskeletal pain management and NSAID demand. The global average opened near USD 31.5/KG in Q1 2025 and closed at USD 33.29/KG in Q4, a full-year gain of about 5.7%. Synthesis feedstock cost dynamics and NSAID musculoskeletal and analgesic procurement drove the quarterly pattern throughout the year.
US prices firmed from about USD 37.5/KG in Q1 2025 to USD 38.5/KG by Q4, a gain of 2.7%. Consistent musculoskeletal pain and post-operative analgesic demand and topical gel procurement supported the upward trend.
Chinese prices firmed from roughly USD 26.1/KG in Q1 2025 to USD 26.8/KG by Q4, a gain of 2.7%. Growing NSAID export and domestic musculoskeletal demand drove modest firming through the year.
German prices firmed from about USD 46.2/KG in Q1 2025 to USD 47.4/KG by Q4, a gain of 2.6%. Consistent musculoskeletal pain, analgesic, and topical anti-inflammatory demand supported the market.
Indian prices firmed from roughly USD 35.2/KG in Q1 2025 to USD 36.2/KG by Q4, a gain of 2.8%. Growing NSAID export and domestic musculoskeletal pain demand drove consistent firming.
Expert Market Research: Your Source for Real-Time Diclofenac Sodium Price Intelligence
Expert Market Research tracks Diclofenac Sodium prices continuously across every major producing and consuming region. The team traces causation through phenylacetic acid synthesis feedstock economics, NSAID and analgesic prescription cycles, and regional API production capacity. Contact Expert Market Research today for Diclofenac Sodium pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Oral and parenteral musculoskeletal pain management for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute low back pain takes the largest share. Post-operative and post-traumatic analgesia, topical gel and patch formulations for localised joint and soft tissue pain, ophthalmic NSAID drops for post-surgical ocular inflammation, and dysmenorrhoea management also consume significant volumes globally.
The Q2 2026 average was USD 40.0/KG in the United States, USD 27.9/KG in China, USD 49.3/KG in Germany, and USD 37.6/KG in India. Germany remains the highest-priced market.
The global average rose from USD 32.62/KG in Q1 to about USD 34.58/KG in Q2, a gain of around 6.0%. Spring musculoskeletal and analgesic procurement and firmer synthesis feedstock costs drove the H1 recovery from the Q1 correction.
Post-year-end musculoskeletal pain and analgesic formulation procurement moderation reduced buying urgency. Soft phenylacetic acid synthesis feedstock costs eased the API production floor before the Q2 spring NSAID procurement recovery.
The global average is expected in the USD 34.90 to 38.80/KG range for H2 2026, with continued firming as synthesis feedstock costs stay elevated and musculoskeletal pain and NSAID sector demand grows with ageing global population demographics.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on NSAID and musculoskeletal demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to phenylacetic acid and aniline synthesis feedstock costs, musculoskeletal pain and NSAID prescription volume cycles, and ageing population demographics driving arthritis demand. Aromatic chemical feedstock prices and osteoarthritis prevalence trends are key signals.
China and India hold the largest diclofenac sodium API production capacity. Any synthesis feedstock cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time NSAID and analgesic formulation contracts around synthesis cost cycles, build cover when phenylacetic acid signals tighten, and monitor musculoskeletal disease prescription volume data as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.